Variant report
Variant | nsv978925 |
---|---|
Chromosome Location | chr2:56497527-56504097 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:56493299..56495631-chr2:56495862..56498685,2 | K562 | blood: | |
2 | chr2:56496763..56498267-chr2:56498962..56500465,2 | K562 | blood: | |
3 | chr2:56501627..56504616-chr2:56522910..56525116,2 | K562 | blood: | |
4 | chr2:56496763..56498267-chr2:56498962..56500465,2 | K562 | blood: | |
5 | chr2:56497998..56500277-chr2:56521559..56523561,2 | MCF-7 | breast: | |
6 | chr2:56495147..56497223-chr2:56498821..56501572,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs531945588 | chr2:56497547-56497548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34019306 | chr2:56497594-56497595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551673532 | chr2:56497600-56497601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551683295 | chr2:56497608-56497609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs571192772 | chr2:56497622-56497623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191141700 | chr2:56497629-56497630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs547545868 | chr2:56497655-56497656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111320384 | chr2:56497672-56497673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183396909 | chr2:56497765-56497766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375566977 | chr2:56497840-56497841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146147712 | chr2:56497849-56497850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569614873 | chr2:56497850-56497851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563024864 | chr2:56497909-56497910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538602048 | chr2:56497956-56497957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558912134 | chr2:56497971-56497972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572321110 | chr2:56497979-56497980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534820521 | chr2:56497991-56497992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79280718 | chr2:56498015-56498016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574096788 | chr2:56498020-56498021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543091889 | chr2:56498062-56498063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562808058 | chr2:56498066-56498067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375833637 | chr2:56498075-56498076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186652874 | chr2:56498081-56498082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544955636 | chr2:56498157-56498158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs140143402 | chr2:56498190-56498191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142413027 | chr2:56498226-56498227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34848805 | chr2:56498246-56498247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs533777579 | chr2:56498276-56498277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547634919 | chr2:56498277-56498278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368265138 | chr2:56498289-56498290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191954918 | chr2:56498301-56498302 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs529783216 | chr2:56498316-56498317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549861120 | chr2:56498317-56498318 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183693430 | chr2:56498321-56498322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187804830 | chr2:56498329-56498330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552160474 | chr2:56498367-56498368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566019594 | chr2:56498370-56498371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs151290315 | chr2:56498382-56498383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554496168 | chr2:56498403-56498404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574591230 | chr2:56498404-56498405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139518836 | chr2:56498415-56498416 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556623396 | chr2:56498440-56498441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191111242 | chr2:56498479-56498480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576089459 | chr2:56498496-56498497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs80095499 | chr2:56498537-56498538 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375229167 | chr2:56498538-56498539 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564936432 | chr2:56498542-56498543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572436764 | chr2:56498550-56498551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541307009 | chr2:56498575-56498576 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561386446 | chr2:56498610-56498611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56486600-56505000 | Weak transcription | Left Ventricle | heart |
2 | chr2:56487800-56506000 | Weak transcription | Psoas Muscle | Psoas |
3 | chr2:56488000-56514000 | Weak transcription | HSMM | muscle |
4 | chr2:56498200-56498600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr2:56498200-56498800 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr2:56498400-56498800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:56498400-56498800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr2:56498400-56499200 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr2:56501800-56504800 | Weak transcription | Aorta | Aorta |
10 | chr2:56502800-56503000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
11 | chr2:56503000-56503200 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr2:56503200-56513400 | Weak transcription | Muscle Satellite Cultured Cells | -- |